[ad_1]
On December 2, the UK became the first country in the world to approve the use of the Pfizer-Bioentech corona vaccine. The vaccine was introduced into the country on December 6. Subsequently, several other countries, including the United States, approved the Pfizer-Bioentech vaccine and began its application.
Pfizer-Bioentech vaccine must be stored at a temperature of minus 60 degrees Celsius. On the other hand, the Oxford-AstraZeneca vaccine can only be stored in the refrigerator.
Like Pfizer, Oxford Ticker also requires two doses. In the case of Pfizer, the interval between the two doses is three weeks. In the case of Oxford, this interval is four weeks.
The Daily Telegraph says that if the Oxford vaccine is approved, it will give many countries in the world confidence to fight the crown.
The Seram Institute of India is one of the partners of the Oxford-AstraZeneca Corona Vaccine Project. The Oxford-AstraZeneca vaccine is being produced in India by the Serum Institute.
The Serum Institute has already applied to the Government of India for approval for the emergency use of the Oxford-AstraZeneca vaccine.
If the Oxford-AstraZeneca corona vaccine is approved for emergency use in India, the people of Bangladesh will also receive it. Prothom Alo published a report on December 15. According to the report, the two countries (Bangladesh and India) have a memorandum of understanding (MoU) with the Seram Institute for simultaneous vaccination in the market.
Researchers say that the Oxford-AstraZeneca vaccine is safe and effective.
